September 11, 2003
|
Anticoagulation and Stroke Prevention in Atrial Fibrillation |
||||||
|
Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy Myocardial ischemia due to coronary microvascular dysfunction is believed to occur in patients with hypertrophic cardiomyopathy and may cause clinical events such as sudden death. In this study, coronary microvascular dysfunction was identified with the use of positron-emission tomography before and after the infusion of dipyridamole, a coronary vasodilator. Microvascular dysfunction, defined as an abnormal response to dipyridamole, was associated with an unfavorable outcome, including death from cardiovascular causes.
|
Substituting Nonnucleoside Reverse-Transcriptase Inhibitors for Protease Inhibitors in the Treatment of HIV-1 In this randomized study of 460 patients receiving effective treatment for human immunodeficiency virus type 1 (HIV-1) disease, nevirapine, efavirenz, or abacavir was substituted for the protease inhibitor in a regimen that also included two nucleoside reverse-transcriptase inhibitors. After 12 months, the increases in CD4 cell counts were similar in the three groups, but there was a trend toward a higher rate of treatment failure in the abacavir group. The substitution of a nonnucleoside reverse-transcriptase inhibitor for a protease inhibitor may reduce the rate of adverse effects while still suppressing viral replication.
|
|||||
|
Health, Life Expectancy, and Health Care Spending among the Elderly Projections of future Medicare expenditures need to take into account the effects of life expectancy and health status on health care costs. In this study of Medicare patients, as expected, better health was associated with lower annual costs and longer lives. For persons in better health, the annual savings were offset by spending over more years, so that expenditures from 70 years of age until death were similar among persons in all initial health states. These findings suggest that improvements in health and longevity among the elderly are unlikely to increase or decrease lifetime Medicare expenditures substantially.
|
Early Alzheimer's Disease A 72-year-old, college-educated woman comes in for the evaluation of mild memory loss that has been gradually progressing for the past two years. The patient drives her own car and manages her own finances, although she has recently made some errors in her checkbook. She also forgot the location of her car in a mall parking lot for two hours. How should this patient be evaluated and treated?
|
|||||
|
Medical Progress: Sudden Death in Young Athletes |
||||||
|
||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |